| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO
1 company
O'Day Daniel Patrick is a Chairman &CEO at Gilead Sciences, Inc.. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $84.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $129.16 | $1,291,608.37 | -0.8% | - | - | |
| Jan 28, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $139.89 | $1,398,911.15 | -0.9% | -7.5% | - | |
| Dec 29, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $124.83 | $1,248,272.00 | -1.7% | +9.2% | - | |
| Nov 28, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $126.54 | $1,265,443.77 | -0.9% | +14.2% | - | |
| Oct 28, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $119.39 | $1,193,925.67 | -0.9% | +16.9% | - | |
| Sep 29, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $111.66 | $1,116,563.99 | -0.8% | +10.9% | - | |
| Aug 28, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $113.63 | $1,136,300.00 | -1.7% | +13.3% | - | |
| Jul 28, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $113.94 | $1,139,369.59 | -0.8% | +6.6% | - | |
| Jun 30, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $110.45 | $1,104,483.74 | -0.8% | +1.6% | - | |
| May 30, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $110.42 | $1,104,192.61 | -0.8% | +2.3% | - |